Where to Buy
Farmaceutical Rx (Frx) is stocked at 59 licensed dispensaries across Ohio and Pennsylvania, 38 of them in Ohio, with the deepest coverage in Cincinnati, Columbus, Athens, Cleveland, and Oxford. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Farmaceutical Rx (Frx) concentrated 90.47% of September 2026 sales in Flower, with Flower up 67.29% month over month and 10.50% year over year, while the average price rose 26.80% year over year to $42.68. Pre-Roll accounted for 8.82% share with no published month-over-month or year-over-year rates, and Edible held 0.70% share after a 149.09% month-over-month rebound but a 91.01% year-over-year drop. The category tilt, paired with a rank of 34 in Flower in Ohio and a 9.31% brand-level year-over-year sales increase versus a 2.51% decline over 24 months, implies the brand is leaning into high-velocity Flower to offset longer-horizon slippage, accepting volatility in minor categories to keep near-term momentum.
The 67.29% month-over-month surge in Flower alongside a 10.50% year-over-year increase, combined with a 0.70% Edible share despite a 149.09% month-over-month spike and a 91.01% year-over-year contraction, signals a focus on core Flower depth rather than breadth. With Flower at 90.47% mix and an average Flower price of $44.88 against the brand’s $42.68 overall, plus a Flower rank of 34 in Ohio, the pattern implies positioning around premium-leaning Flower throughput while keeping Pre-Roll as a secondary channel and using Edible tactically for episodic lift rather than sustained share.
Competitive Landscape
Farmaceutical Rx (Frx) sits at rank #34 in OH Flower in September 2026, down 4 places year over year from #30, but up 10 positions versus June 2026 when it was #44; against this, Klutch Cannabis advanced from #13 to #1 while its sales grew 162.4% year over year, and Northwoods Cannabis surged 76 ranks to #5 with a 105,837.8% sales increase. Although Farmaceutical Rx (Frx) peaked at #21 in August 2025 and now trails leaders as King City Gardens moved from #10 to #2 and RYTHM climbed from #7 to #4 alongside a 10.4% sales lift, the 10-rank rise since June 2026 implies a recovery trajectory that requires sustained velocity to avoid being outpaced by faster-ascending incumbents.

Notable Products
Animal Face (2.83g) posted the steepest movement in September 2026 with a -64.8% month-over-month drop while holding rank 10, contrasting with Ghost OG (2.83g) at rank 8 falling -25.2% month over month. Guwop Green (7g) led the lineup at rank 1 and Znacks Mini (5.66g) followed at rank 2, and four of the top ten are 7g Smalls/Minis formats that cluster between ranks 1 and 9. With rank stability concentrated at the top and double-digit declines isolated to smaller 2.83g packs, the mix signals Farmaceutical Rx (Frx) is tilting toward larger-value Flower formats even as select small-pack SKUs retrench.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







